Vancomycin: An analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population.
- Published in:
- Pharmacotherapy, 2024, v. 44, n. 6, p. 425, doi. 10.1002/phar.2941
- By:
- Publication type:
- Article
Works matching IS 02770008 AND DT 2024 AND VI 44 AND IP 6
Results: 7
1
2
Increasing the bioavailability of oral esketamine by a single dose of cobicistat: A case study.
- Published in:
- Pharmacotherapy, 2024, v. 44, n. 6, p. 480, doi. 10.1002/phar.2942
- By:
- Publication type:
- Article
3
The efficacy and safety of sodium‐glucose cotransporter‐2 inhibitors in solid organ transplant recipients: A scoping review.
- Published in:
- Pharmacotherapy, 2024, v. 44, n. 6, p. 444, doi. 10.1002/phar.2928
- By:
- Publication type:
- Article
4
Phase I study of the pharmacokinetics and safety of rezafungin in subjects with moderate/severe hepatic impairment and matched control subjects.
- Published in:
- Pharmacotherapy, 2024, v. 44, n. 6, p. 435, doi. 10.1002/phar.2943
- By:
- Publication type:
- Article
5
Management of invasive candidiasis: A focus on rezafungin, ibrexafungerp, and fosmanogepix.
- Published in:
- Pharmacotherapy, 2024, v. 44, n. 6, p. 467, doi. 10.1002/phar.2926
- By:
- Publication type:
- Article
6
Genetic polymorphisms and major bleeding risk during vitamin K antagonists treatment: The BLEEDS case‐cohort.
- Published in:
- Pharmacotherapy, 2024, v. 44, n. 6, p. 416, doi. 10.1002/phar.2923
- By:
- Publication type:
- Article
7
Issue Information.
- Published in:
- Pharmacotherapy, 2024, v. 44, n. 6, p. 413, doi. 10.1002/phar.2695
- Publication type:
- Article